DevvStream
Hillcrest Energy Technologies

Maxeon Solar Technologies Announces Fourth Quarter and Fiscal Year 2022 Financial Results

  • Record Gross Profit of $20 million in fourth quarter of 2022
  • Guiding Positive Adj. EBITDA in first quarter of 2023

SINGAPORE, March 7, 2023 /PRNewswire/ -- Maxeon Solar Technologies, Ltd. (NASDAQ:MAXN) ("Maxeon" or "the Company"), a global leader in solar innovation and channels, today announced its financial results for its fourth quarter and fiscal year ended January 1, 2023.

Maxeon's Chief Executive Officer Bill Mulligan noted, "After more than two years of investment in significant transformation initiatives, Maxeon's financial performance is improving rapidly. The Company's gross profit increased to $20 million in the fourth quarter due to strong operational performance and prudent supply chain management, a record for Maxeon. Next quarter, Maxeon projects further progress leading to positive adjusted EBITDA for the first time since our spin-out. This continued margin improvement is attributable to strong execution by both our manufacturing and sales teams. In our distributed generation (DG) business, pricing is benefiting from continued strength in our European channel with increasing attach rates for Beyond the Panel products, and also in the United States (US) with strong demand from both SunPower as well as through our new Maxeon installer channel which kicked off in January. Our US DG partners indicate significant year-over-year growth for us in 2023, which we attribute in part to our products' popularity in high-cost-of-power markets and sales professionals skilled at selling long-term value."

Mulligan continued "The US utility-scale business is poised for further growth with cumulative bookings now 4.2 gigawatts extending deep into 2025 plus options with advance deposits for an additional 1.5 gigawatts through 2027. Our first 1.8GW of Performance Line manufacturing capacity is on track to reach full output later this year. With the majority of the ramp already completed, we expect improving COGS to drive positive adjusted EBITDA in the current quarter."  

Selected Q4 and Fiscal Year Unaudited Financial Summary

 

(In thousands, except shipments)

Fiscal Q4 2022

 

Fiscal Q3 2022

 

Fiscal Q4 2021

 

Fiscal Year 2022

 

Fiscal Year 2021

Shipments, in MW

734

 

605

 

577

 

2,348

 

1,956

Revenue

$           323,503

 

$           275,449

 

$           221,479

 

$             1,060,113

 

$                783,279

Gross profit (loss)(1)

20,087

 

(15,747)

 

(10,545)

 

(47,948)

 

(29,014)

GAAP Operating expenses

38,038

 

41,196

 

35,518

 

152,346

 

143,433

GAAP Net loss attributable to the
stockholders(1)

(75,701)

 

(44,691)

 

(73,332)

 

(267,424)

 

(254,520)

Capital expenditures

7,314

 

16,110

 

37,393

 

63,337

 

154,194

 

Other Financial Data(1), (2)

(In thousands)

Fiscal Q4 2022

 

Fiscal Q3 2022

 

Fiscal Q4 2021

 

Fiscal Year 2022

 

Fiscal Year 2021

Non-GAAP Gross profit (loss)(1)

$             20,696

 

$            (15,492)

 

$            (10,056)

 

$                (31,243)

 

$                (27,764)

Non-GAAP Operating expenses

34,488

 

34,651

 

33,423

 

133,669

 

129,368

Adjusted EBITDA(1)

(3,712)

 

(34,501)

 

(32,777)

 

(108,636)

 

(116,824)

  

(1)

The Company's GAAP and Non-GAAP results were impacted by the effects of certain items. Refer to "Supplementary information affecting GAAP and Non-GAAP results" below.

  

(2)

The Company's use of Non-GAAP financial information, including a reconciliation to U.S. GAAP, is provided under "Use of Non-GAAP Financial Measures" below.

Supplementary information affecting GAAP and Non-GAAP results

 
  

Three Months Ended

 

Fiscal Year Ended

(In thousands)

Financial
statements
item affected

January 1,
2023

 

October 2,
2022

 

January 2, 2022

 

January 1, 2023

 

January 2, 2022

Incremental cost
of above market
polysilicon(1)

Cost of revenue

30

 

603

 

11,542

 

11,329

 

47,188

Loss on ancillary
sales of excess
polysilicon(2)

Cost of revenue

 

 

2,621

 

8,328

 

14,264

  

(1)

Relates to the difference between our contractual cost for the polysilicon under the long-term fixed supply agreements with our supplier and the price of polysilicon available in the market as derived from publicly available information at the beginning of each quarter, multiplied by the volume of modules sold within the quarter.

  

(2)

In order to reduce inventory and improve working capital, we had periodically elected to sell polysilicon inventory procured under the long-term fixed supply agreements in the market at prices below our purchase price, thereby incurring a loss.

Fiscal Year 2023 and First Quarter 2023 Outlook

For the first quarter of 2023, the Company anticipates the following results:

(In millions, except shipments)

 Outlook

Shipments, in MW

730 - 770 MW

Revenue

$305 - $345

Gross profit

$29 - $39

Non-GAAP gross profit(1)

$30 - $40

Operating expenses

$41 ± $2

Non-GAAP operating expenses(2)

$37 ± $2

Adjusted EBITDA(3)

$10 - $20

Capital expenditures(4)

$13 - $17

For fiscal year 2023, the Company anticipates the following results:

  • Revenue to be within a range of $1,350 million to $1,550 million.
  • Adjusted EBITDA(3) to be within a range of $80 million to $100 million.
  • Capital expenditures(4) to be within a range of $100 million to $120 million.

(1)

The Company's Non-GAAP gross profit is impacted by the effects of adjusting for stock-based compensation expense.

  

(2)

The Company's Non-GAAP operating expenses are impacted by the effects of adjusting for stock-based compensation expense and restructuring charges and fees.

  

(3)

The Company cannot provide a reconciliation between its Adjusted EBITDA projection and the most directly comparable GAAP measures without unreasonable efforts because it is unable to predict with reasonable certainty the ultimate outcome of the remeasurement gain or loss of the prepaid forward and the equity in income or losses of our unconsolidated investee.

  

(4)

The capital expenditures mainly relate to preparation for capacity expansion for our Maxeon 7 technology, completion of manufacturing capacity for Performance line panels to be sold in the U.S. market, completion of manufacturing capacity for our Maxeon 6 product platform, further developing Maxeon 7 technology and operating a pilot line, as well as various corporate initiatives. The above excludes capital expenditures in connection to the investment plan to deploy a multi-GW factory in the United States to manufacture solar products for both the DG and utility-scale power plant markets.

These anticipated results for fiscal year 2023 and the first quarter of 2023 are preliminary, unaudited and represent the most current information available to management. The Company's business outlook is based on management's current views and estimates with respect to market conditions, production capacity, the uncertainty of the continuing COVID-19 pandemic, and the global economic environment. Please refer to Forward Looking Statements section below. Management's views and estimates are subject to change without notice.

For more information

Maxeon's fiscal year 2022 financial results and management commentary can be found on Form 20-F by accessing the Financials & Filings page of the Investor Relations section of Maxeon's website at: https://corp.maxeon.com/investor-relations. The Form 20-F and Company's other filings are also available online from the Securities and Exchange Commission at www.sec.gov.

Conference Call Details

The Company will hold a conference call on March 7, 2023, at 5:00 PM U.S. ET / March 8, 2023, at 6:00 AM Singapore Time, to discuss results and provide an update on the business.

To join the live conference call, participants must first register here, where a dial-in number will be provided.

A simultaneous audio-only webcast of the conference call will also be available on Maxeon's website at https://edge.media-server.com/mmc/p/npaoiv87. A webcast replay will be available on Maxeon's website for one year at https://corp.maxeon.com/events-and-presentations.

About Maxeon Solar Technologies

Maxeon Solar Technologies Ltd (NASDAQ: MAXN) is Powering Positive Change. Headquartered in Singapore, Maxeon designs and manufactures Maxeon® and SunPower® brand solar panels, and has sales operations in more than 100 countries, operating under the SunPower brand in certain countries outside the United States. The Company is a leader in solar innovation with access to over 1,000 patents and two best-in-class solar panel product lines. Maxeon products span the global rooftop and solar power plant markets through a network of more than 1,700 trusted partners and distributors. A pioneer in sustainable solar manufacturing, Maxeon leverages a +35-year history in the solar industry and numerous awards for its technology. For more information about how Maxeon is Powering Positive Change visit us at https://www.maxeon.com/, on LinkedIn and on Twitter.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, but not limited to, statements regarding: (a) our expectations regarding pricing trends, demand and growth projections; (b) potential disruptions to our operations and supply chain that may result from epidemics, natural disasters or military conflicts, including the duration, scope and impact on the demand for our products, market disruptions from the war in Ukraine and the pace of recovery from the COVID-19 pandemic; (c) anticipated product launch timing and our expectations regarding ramp, customer acceptance and demand, upsell and expansion opportunities; (d) our expectations and plans for short- and long-term strategy, including our anticipated areas of focus and investment, market expansion, product and technology focus, and projected growth and profitability; (e) our ability to meet short-term and long-term material cash requirements, our ability to complete an equity or debt offering at favorable terms, if at all, and our overall liquidity, substantial indebtedness and ability to obtain additional financing; (f) our technology outlook, including anticipated fab capacity expansion and utilization and expected ramp and production timelines for the Company's Maxeon 6, next-generation Maxeon 7 and Performance line solar panels, expected cost reductions, and future performance; (g) our strategic goals and plans, including partnership discussions with respect to the Company's next-generation technology, and our relationships with existing customers, suppliers and partners, and our ability to achieve and maintain them; (h) our expectations regarding our future performance and revenues resulting from contracted orders, bookings, backlog, pipelines in our sales channels and feedback from our partners; (i) our projected effective tax rate and changes to the valuation allowance related to our deferred tax assets; and (j) our first quarter and annual fiscal year 2023 guidance, including shipments, revenue, gross profit (loss), non-GAAP gross profit (loss), operating expenses, non-GAAP operating expenses, Adjusted EBITDA, capital expenditures, out-of-market polysilicon cost and related assumptions.

The forward-looking statements can be also identified by terminology such as "may," "projects,""indicate," "expect," "anticipates," "future," "plans," "believes," "estimates," "outlook" and similar statements.  Among other things, the quotations from management in this press release and Maxeon's operations and business outlook contain forward-looking statements.

These forward-looking statements are based on our current assumptions, expectations and beliefs and involve substantial risks and uncertainties that may cause results, performance or achievement to materially differ from those expressed or implied by these forward-looking statements. These statements are not guarantees of future performance and are subject to a number of risks. The reader should not place undue reliance on these forward-looking statements, as there can be no assurances that the plans, initiatives or expectations upon which they are based will occur. Factors that could cause or contribute to such differences include, but are not limited to: (1) challenges in executing transactions key to our strategic plans, including regulatory and other challenges that may arise; (2) our liquidity, substantial indebtedness, terms and conditions upon which our indebtedness is incurred, and ability to obtain additional financing for our projects, customers and operations; (3) our ability to manage supply chain shortages and cost increases and operating expenses; (4) potential disruptions to our operations and supply chain that may result from damage or destruction of facilities operated by our suppliers, difficulties in hiring or retaining key personnel, epidemics, natural disasters, including impacts of the COVID-19 pandemic, or the war in Ukraine; (5) our ability to manage our key customers and suppliers; (6) the success of our ongoing research and development efforts and our ability to commercialize new products and services, including products and services developed through strategic partnerships; (7) competition in the solar and general energy industry and downward pressure on selling prices and wholesale energy pricing, including impacts of inflation, economic recession and foreign exchange rates upon customer demand; (8) changes in regulation and public policy, including the imposition and applicability of tariffs; (9) our ability to comply with various tax holiday requirements as well as regulatory changes or findings affecting the availability of economic incentives promoting use of solar energy and availability of tax incentives or imposition of tax duties; (10) fluctuations in our operating results and in the foreign currencies in which we operate; (11) appropriately sizing, or delays in expanding our manufacturing capacity and containing manufacturing and logistics difficulties that could arise; (12) unanticipated impact to customer demand and sales schedules due, among other factors, to the spread of COVID-19, the war in Ukraine, economic recession and environmental disasters; (13) challenges managing our acquisitions, joint ventures and partnerships, including our ability to successfully manage acquired assets and supplier relationships; (14) reaction by securities or industry analysts to our quarterly guidance which, in combination with our results of operations or other factors, may cause them to cease publishing research or reports about us, or adversely change their recommendations regarding our ordinary shares, which may negatively impact the market price of our ordinary shares and volume of our stock trading; and (15) unpredictable outcomes resulting from our litigation activities or other disputes. A detailed discussion of these factors and other risks that affect our business is included in filings we make with the Securities and Exchange Commission ("SEC") from time to time, including our most recent report on Form 20-F, particularly under the heading "Risk Factors". Copies of these filings are available online from the SEC at www.sec.gov, or on the SEC Filings section of our Investor Relations website at https://corp.maxeon.com/investor-relations. All forward-looking statements in this press release are based on information currently available to us, and we assume no obligation to update these forward-looking statements in light of new information or future events.

Use of Non-GAAP Financial Measures

We present certain non-GAAP measures such as non-GAAP gross profit (loss), non-GAAP operating expenses and earnings before interest, taxes, depreciation and amortization ("EBITDA") adjusted for stock-based compensation, restructuring charges and fees, remeasurement loss (gain) on prepaid forward and physical delivery forward, loss on extinguishment of debt, impairment, equity in losses of unconsolidated investees and related gains and loss related to settlement of price escalation dispute ("Adjusted EBITDA") to supplement our consolidated and combined financial results presented in accordance with GAAP. Non-GAAP gross profit (loss) is defined as gross profit (loss) excluding stock-based compensation and loss related to settlement of price escalation dispute. Non-GAAP operating expenses is defined as operating expenses excluding stock-based compensation and restructuring charges and fees.

We believe that non-GAAP gross profit (loss), non-GAAP operating expenses and Adjusted EBITDA provide greater transparency into management's view and assessment of the Company's ongoing operating performance by removing items management believes are not representative of our continuing operations and may distort our longer-term operating trends. We believe these measures are useful to help enhance the comparability of our results of operations across different reporting periods on a consistent basis and with our competitors, distinct from items that are infrequent or not associated with the Company's core operations as presented above. We also use these non-GAAP measures internally to assess our business, financial performance and current and historical results, as well as for strategic decision-making and forecasting future results. Given our use of non-GAAP measures, we believe that these measures may be important to investors in understanding our operating results as seen through the eyes of management. These non-GAAP measures are neither prepared in accordance with GAAP nor are they intended to be a replacement for GAAP financial data, should be reviewed together with GAAP measures and may be different from non-GAAP measures used by other companies.

As presented in the "Reconciliation of Non-GAAP Financial Measures" section, each of the non-GAAP financial measures excludes one or more of the following items in arriving to the non-GAAP measures:

  • Stock-based compensation expense. Stock-based compensation relates primarily to equity incentive awards. Stock-based compensation is a non-cash expense that is dependent on market forces that are difficult to predict and is excluded from non-GAAP gross loss, non-GAAP operating expense and Adjusted EBITDA. Management believes that this adjustment for stock-based compensation expense provides investors with a basis to measure our core performance, including the ability to compare our performance with the performance of other companies, without the period-to-period variability created by stock-based compensation.
  • Restructuring charges and fees. We incur restructuring charges and fees related to reorganization plans aimed towards realigning resources consistent with our global strategy and improving its overall operating efficiency and cost structure. Restructuring charges and fees are excluded from non-GAAP operating expenses and Adjusted EBITDA because they are not considered core operating activities. Although we have engaged in restructuring activities and initiatives, past activities have been discrete events based on unique sets of business objectives. As such, management believes that it is appropriate to exclude restructuring charges and fees from our non-GAAP financial measures as they are not reflective of ongoing operating results nor do these charges contribute to a meaningful evaluation of our past operating performance.
  •  Remeasurement loss (gain) on prepaid forward and physical delivery forward. This relates to the mark-to-market fair value remeasurement of privately negotiated prepaid forward and physical delivery transactions. The transactions were entered into in connection with the issuance on July 17, 2020 of the 6.50% Green Convertible Senior Notes due 2025 for an aggregate principal amount of $200.0 million. The prepaid forward is remeasured to fair value at the end of each reporting period, with changes in fair value booked in earnings. The fair value of the prepaid forward is primarily affected by the Company's share price. The physical delivery forward was remeasured to fair value at the end of the Note Valuation Period on September 29, 2020, and was reclassified to equity after remeasurement, and will not be subsequently remeasured. The fair value of the physical delivery forward was primarily affected by the Company's share price. The remeasurement loss (gain) on prepaid forward and physical delivery forward is excluded from Adjusted EBITDA because it is not considered core operating activities. As such, management believes that it is appropriate to exclude these mark-to-market adjustments from our Adjusted EBITDA as they are not reflective of ongoing operating results nor do the loss (gain) contribute to a meaningful evaluation of our past operating performance.
  • Loss on extinguishment of debt. This relates to the loss that arose from the termination of our $50.0 million working capital facility in September 2021 and the expiration of the availability period for draw down of our $75.0 million term loans in August 2021. Loss on debt extinguishment is excluded from Adjusted EBITDA because it is not considered part of core operating activities. Such activities are discrete events based on unique sets of business objectives. As such, management believes that it is appropriate to exclude the loss on extinguishment of debt from our non-GAAP financial measures as it is not reflective of ongoing operating results nor do these charges contribute to a meaningful evaluation of our past operating performance.
  • Impairment. This relates to the impairment of assets recorded by our equity method investee, Huansheng JV. Asset impairment is excluded from our Adjusted EBITDA financial measure as it is non-cash in nature and not reflective of ongoing operating results. As such, management believes that it is appropriate to exclude such charges as they do not contribute to a meaningful evaluation of our past operating performance.
  • Equity in losses of unconsolidated investees and related gains. This relates to the loss on our unconsolidated equity investment Huansheng JV and gains on such investment. This is excluded from our Adjusted EBITDA financial measure as it is non-cash in nature and not reflective of our core operational performance. As such, management believes that it is appropriate to exclude such charges as they do not contribute to a meaningful evaluation of our performance.
  • Loss related to settlement of price escalation dispute. This relates to loss arising from the settlement of price escalation dispute with a polysilicon supplier related to our long-term, firm commitment polysilicon supply agreement. This is excluded from our Adjusted EBITDA financial measure as it is non-recurring and not reflective of ongoing operating results. As such, management believes that it is appropriate to exclude such charges as the loss does not contribute to a meaningful evaluation of our past operating performance.

Reconciliation of Non-GAAP Financial Measures

 
 

Three Months Ended

 

Fiscal Year Ended

(In thousands)

January 1,
2023

 

October 2, 2022

 

January 2,
2022

 

January 1,
2023

 

January 2,
2022

Gross profit (loss)

$               20,087

 

$              (15,747)

 

$              (10,545)

 

$              (47,948)

 

$              (29,014)

Stock-based compensation

609

 

255

 

489

 

1,535

 

1,250

Loss related to settlement of price
escalation dispute

 

 

 

15,170

 

Non-GAAP Gross profit (loss)

20,696

 

(15,492)

 

(10,056)

 

(31,243)

 

(27,764)

          

GAAP Operating expenses

38,038

 

41,196

 

35,518

 

152,346

 

143,433

Stock-based compensation

(2,956)

 

(5,918)

 

(1,545)

 

(13,045)

 

(5,981)

Restructuring charges and fees

(594)

 

(627)

 

(550)

 

(5,632)

 

(8,084)

Non-GAAP Operating expenses

34,488

 

34,651

 

33,423

 

133,669

 

129,368

          

GAAP Net loss attributable to the
stockholders

(75,701)

 

(44,691)

 

(73,332)

 

(267,424)

 

(254,520)

Interest expense, net

9,307

 

8,035

 

6,511

 

27,812

 

27,848

Provision for (benefit from) income
taxes

28,030

 

2,399

 

(1,016)

 

32,191

 

203

Depreciation

14,422

 

13,845

 

11,930

 

56,470

 

41,827

Amortization

57

 

50

 

185

 

272

 

383

EBITDA

(23,885)

 

(20,362)

 

(55,722)

 

(150,679)

 

(184,259)

Impairment

 

 

5,058

 

 

$                  5,058

Stock-based compensation

3,565

 

6,173

 

2,034

 

14,580

 

$                  7,231

Loss related to settlement of price
escalation dispute

 

 

 

15,170

 

$                       —

Restructuring charges (credits) and
fees(1)

594

 

627

 

(378)

 

5,632

 

$                  7,156

Remeasurement loss (gain) on
physical delivery forward and
prepaid forward

17,726

 

(24,521)

 

9,827

 

(2,411)

 

$               34,468

Equity in (income) losses of
unconsolidated investees and related
gain

(1,712)

 

3,582

 

6,404

 

9,072

 

$                  8,447

Loss on extinguishment of debt

 

 

 

 

$                  5,075

Adjusted EBITDA(2)

(3,712)

 

(34,501)

 

(32,777)

 

(108,636)

 

$           (116,824)

  

(1)

Amount represents restructuring charges and fees related to reorganization plans, excluding accelerated depreciation amounting to $0.9 million included in the depreciation line for the three months ended January 2, 2022 and fiscal year 2021.

  

(2)

The Adjusted EBITDA for three months ended January 2, 2022 did not contain an adjustment for equity in losses of unconsolidated investees and related gain on such equity investment. For a reconciliation of Adjusted EBITDA to GAAP Net Loss for the three months ended January 2, 2022, please refer to our Forms 6-K furnished with the SEC on March 24, 2022.

Reconciliation of Non-GAAP Outlook

 

(In millions)

Outlook

Gross profit

$29 - $39

Stock-based compensation

1

Non-GAAP gross profit

$30 - $40

  

Operating expenses

$41 ± $2

Stock-based compensation

(4)

Non-GAAP operating expenses

$37 ± $2

©2023 Maxeon Solar Technologies, Ltd. All rights reserved. MAXEON is a registered trademark of Maxeon Solar Technologies, Ltd. Visit https://corp.maxeon.com/trademarks for more information.

MAXEON SOLAR TECHNOLOGIES, LTD.

CONDENSED CONSOLIDATED BALANCE SHEETS

(unaudited)

(In thousands, except for shares data)

 
 

As of

 

January 1, 2023

 

January 2, 2022

Assets

   

Current assets:

   

Cash and cash equivalents

$                227,442

 

$                 166,542

Short-term securities

76,000

 

Restricted short-term marketable securities

968

 

1,079

Accounts receivable, net

54,301

 

39,730

Inventories

303,230

 

212,820

Advances to suppliers, current portion

2,137

 

51,045

Prepaid expenses and other current assets

126,971

 

61,904

Total current assets

$                791,049

 

$                 533,120

Property, plant and equipment, net

380,468

 

386,630

Operating lease right of use assets

17,844

 

15,397

Intangible assets, net

291

 

420

Advances to suppliers, net of current portion

 

716

Deferred tax assets

10,348

 

5,183

Other long-term assets

60,418

 

115,077

Total assets

$             1,260,418

 

$              1,056,543

Liabilities and Equity

   

Current liabilities:

   

Accounts payable

$                247,870

 

$                 270,475

Accrued liabilities

135,157

 

78,680

Contract liabilities, current portion

139,267

 

44,059

Short-term debt

50,526

 

25,355

Operating lease liabilities, current portion

3,412

 

2,467

Total current liabilities

$                576,232

 

$                 421,036

Long-term debt

1,649

 

213

Contract liabilities, net of current portion

161,678

 

58,994

Operating lease liabilities, net of current portion

15,603

 

13,464

Convertible debt

378,610

 

145,772

Deferred tax liabilities

14,913

 

1,150

Other long-term liabilities

63,663

 

61,039

Total liabilities

$             1,212,348

 

$                 701,668

Commitments and contingencies

   

Equity:

   

Common stock, no par value (45,033,027 and 44,246,603  issued and outstanding as of
January 1, 2023 and  January 2, 2022, respectively)

$                          —

 

$                           —

Additional paid-in capital

584,808

 

624,261

Accumulated deficit

(520,263)

 

(262,961)

Accumulated other comprehensive loss

(22,108)

 

(11,844)

Equity attributable to the Company

42,437

 

349,456

Noncontrolling interests

5,633

 

5,419

Total equity

48,070

 

354,875

Total liabilities and equity

$             1,260,418

 

$              1,056,543

MAXEON SOLAR TECHNOLOGIES, LTD.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited)

(In thousands, except per share data)

 
 

Three Months Ended

 

Fiscal Year Ended

 

January 1, 2023

 

January 2, 2022

 

January 1, 2023

 

January 2, 2022

Revenue

$                 323,503

 

$                 221,479

 

$              1,060,113

 

$                 783,279

Cost of revenue

303,416

 

232,024

 

1,108,061

 

812,293

Gross profit (loss)

20,087

 

(10,545)

 

(47,948)

 

(29,014)

Operating expenses:

       

Research and development

11,403

 

10,700

 

49,682

 

46,527

Sales, general and administrative

26,132

 

24,268

 

100,546

 

88,822

Restructuring charges

503

 

550

 

2,118

 

8,084

Total operating expenses

38,038

 

35,518

 

152,346

 

143,433

Operating loss

(17,951)

 

(46,063)

 

(200,294)

 

(172,447)

Other expense, net

       

Interest expense, net

(9,307)

 

(6,511)

 

(27,812)

 

(27,848)

Loss on extinguishment of debt

 

 

 

(5,075)

Other, net

(22,129)

 

(10,574)

 

2,223

 

(33,693)

Other expense, net

(31,436)

 

(17,085)

 

(25,589)

 

(66,616)

Loss before income taxes and equity in losses
of unconsolidated investees

(49,387)

 

(63,148)

 

(225,883)

 

(239,063)

(Provision for) benefit from income taxes

(28,030)

 

1,016

 

(32,191)

 

(203)

Equity in income (losses) of unconsolidated
investees

1,712

 

(11,462)

 

(9,072)

 

(16,480)

Net loss

(75,705)

 

(73,594)

 

(267,146)

 

(255,746)

Net loss (income) attributable to
noncontrolling interests

4

 

262

 

(278)

 

1,226

Net loss attributable to the stockholders

$                  (75,701)

 

$                  (73,332)

 

$               (267,424)

 

$               (254,520)

        

Net loss per share attributable to stockholders:

       

Basic and diluted

$                      (1.84)

 

$                      (1.81)

 

$                      (6.54)

 

$                      (6.79)

        

Weighted average shares used to compute net
loss per share:

       

Basic and diluted

41,227

 

40,444

 

40,920

 

37,457

MAXEON SOLAR TECHNOLOGIES, LTD.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited)

(In thousands)

 
 

Fiscal Year Ended

 

January 1, 2023

 

January 2, 2022

Cash flows from operating activities

   

Net loss

$             (267,146)

 

$                (255,746)

Adjustments to reconcile net loss to net cash used in operating
activities

   

Depreciation and amortization

56,219

 

42,210

Stock-based compensation

14,580

 

7,231

Non-cash interest expense

7,078

 

13,361

Equity in losses of unconsolidated investees

9,072

 

16,480

Gain from dilution of interest in joint venture

 

(2,975)

Loss on retirement of property, plant and equipment

243

 

2,442

Loss on impairment of property, plant and equipment

417

 

Loss on debt extinguishment

 

5,075

Deferred income taxes

8,598

 

5,587

Remeasurement (gain) loss on prepaid forward

(2,411)

 

34,468

Reserves (utilization) for excess or obsolete inventories

16,342

 

(319)

Other, net

1,607

 

(1,765)

Changes in operating assets and liabilities

   

Accounts receivable

(15,332)

 

38,268

Inventories

(106,622)

 

(43,174)

Prepaid expenses and other assets

(35,685)

 

(20,529)

Operating lease right-of-use assets

3,192

 

2,449

Advances to suppliers

49,624

 

41,147

Accounts payable and other accrued liabilities

70,567

 

41,098

Contract liabilities

195,650

 

72,488

Operating lease liabilities

(2,556)

 

(2,662)

Net cash provided by (used in) operating activities

3,437

 

(4,866)

Cash flows from investing activities

   

Purchases of property, plant and equipment

(63,337)

 

(154,194)

Proceeds from disposal of restricted short-term marketable
securities

958

 

1,318

Purchase of restricted short-term marketable securities

(968)

 

(1,094)

Purchase of short-term securities

(76,000)

 

Proceeds from (cash paid for) disposal of property, plant and
equipment

189

 

(417)

Purchases of intangibles

(143)

 

(61)

Net cash used in investing activities

(139,301)

 

(154,448)

Cash flows from financing activities

   

Proceeds from debt

258,426

 

170,311

Repayment of debt

(233,138)

 

(193,237)

Payment for tax withholding obligations for issuance of common
stock upon vesting of restricted stock units

(257)

 

(4,245)

Net proceeds from issuance of convertible debt

187,232

 

Net proceeds from issuance of common stock

 

169,684

Distribution to noncontrolling interest

(64)

 

Repayment of finance lease obligations and other debt

(725)

 

(705)

Net cash provided by financing activities

211,474

 

141,808

Effect of exchange rate changes on cash, cash equivalents, restricted
cash and restricted cash equivalents

119

 

166

Net increase (decrease) in cash, cash equivalents, restricted cash and
restricted cash equivalents

75,729

 

(17,340)

Cash, cash equivalents, restricted cash and restricted cash equivalents,
beginning of period

192,232

 

209,572

Cash, cash equivalents, restricted cash and restricted cash equivalents,
end of period

$                267,961

 

$                   192,232

Non-cash transactions

   

Property, plant and equipment purchases funded by liabilities

$                   35,264

 

$                     58,562

Right-of-use assets obtained in exchange for lease obligations

5,639

 

5,029

Cost from issuance of common stock paid in shares

 

1,078

Property, plant and equipment obtained through capital lease

2,127

 

The following table reconciles our cash and cash equivalents and restricted cash and restricted cash equivalents reported on our Condensed Consolidated Balance Sheets and the cash, cash equivalents, restricted cash and restricted cash equivalents reported on our Condensed Consolidated Statements of Cash Flows as of January 1, 2023 and January 2, 2022:

(In thousands)

January 1, 2023

 

January 2, 2022

Cash and cash equivalents

$                  227,442

 

$                    166,542

Restricted cash and restricted cash equivalents, current portion,
     included in prepaid expenses and other current assets

37,974

 

1,661

Restricted cash and restricted cash equivalents, net of current portion,
     included in other long-term assets

2,545

 

24,029

Total cash, cash equivalents, restricted cash and restricted cash
     equivalents shown in Condensed Consolidated Statements of Cash
     Flows

$                  267,961

 

$                    192,232

Sign Up for Daily Green Stock News

Sign up for the free daily newsletter to tap into the pulse of emerging green sectors each day. Get top daily headlines from clean energy, cleantech, cannabis, and sustainable transport stocks, delivered to your email inbox:

Please review our Disclaimer and Privacy Policy before subscribing. You can unsubscribe at any time.

Sign Up To Get Daily Green Stock News In Your Inbox

Please review our Disclaimer and Privacy Policy before subscribing.
Else Nutrition

Else Nutrition is changing the face of early childhood nutrition with clean, sustainable, plant-based products. The company has developed the world’s first whole plant-based infant formula that is targeting the $100+ billion global...

CLICK TO LEARN MORE
UGE International

UGE International develops, owns, and operates commercial and community solar projects in the United States and strategic markets abroad. Our distributed energy solutions deliver cheaper, cleaner energy to businesses and consumers...

CLICK TO LEARN MORE

COPYRIGHT ©2022 GREEN STOCK NEWS